tetano
Editor, Senior Moderator
Sci Rep
. 2023 Oct 6;13(1):16867.
doi: 10.1038/s41598-023-43040-x. Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 +
Massimo Bellato[SUP] #[/SUP][SUP] 1 [/SUP], Marco Cappellato[SUP] #[/SUP][SUP] 1 [/SUP], Francesca Longhin[SUP] #[/SUP][SUP] 1 [/SUP], Claudia Del Vecchio[SUP] 2 [/SUP], Giuseppina Brancaccio[SUP] 2 3 [/SUP], Anna Maria Cattelan[SUP] 2 3 [/SUP], Paola Brun[SUP] 2 [/SUP], Claudio Salaris[SUP] 2 [/SUP], Ignazio Castagliuolo[SUP] #[/SUP][SUP] 2 4 [/SUP], Barbara Di Camillo[SUP] #[/SUP][SUP] 5 6 [/SUP]
Affiliations
The outbreak of Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, forced us to face a pandemic with unprecedented social, economic, and public health consequences. Several nations have launched campaigns to immunize millions of people using various vaccines to prevent infections. Meanwhile, therapeutic approaches and discoveries continuously arise; however, identifying infected patients that are going to experience the more severe outcomes of COVID-19 is still a major need, to focus therapeutic efforts, reducing hospitalization and mitigating drug adverse effects. Microbial communities colonizing the respiratory tract exert significant effects on host immune responses, influencing the susceptibility to infectious agents. Through 16S rDNAseq we characterized the upper airways' microbiota of 192 subjects with nasopharyngeal swab positive for SARS-CoV-2. Patients were divided into groups based on the presence of symptoms, pneumonia severity, and need for oxygen therapy or intubation. Indeed, unlike most of the literature, our study focuses on identifying microbial signatures predictive of disease progression rather than on the probability of infection itself, for which a consensus is lacking. Diversity, differential abundance, and network analysis at different taxonomic levels were synergistically adopted, in a robust bioinformatic pipeline, highlighting novel possible taxa correlated with patients' disease progression to intubation.
. 2023 Oct 6;13(1):16867.
doi: 10.1038/s41598-023-43040-x. Uncover a microbiota signature of upper respiratory tract in patients with SARS-CoV-2 +
Massimo Bellato[SUP] #[/SUP][SUP] 1 [/SUP], Marco Cappellato[SUP] #[/SUP][SUP] 1 [/SUP], Francesca Longhin[SUP] #[/SUP][SUP] 1 [/SUP], Claudia Del Vecchio[SUP] 2 [/SUP], Giuseppina Brancaccio[SUP] 2 3 [/SUP], Anna Maria Cattelan[SUP] 2 3 [/SUP], Paola Brun[SUP] 2 [/SUP], Claudio Salaris[SUP] 2 [/SUP], Ignazio Castagliuolo[SUP] #[/SUP][SUP] 2 4 [/SUP], Barbara Di Camillo[SUP] #[/SUP][SUP] 5 6 [/SUP]
Affiliations
- PMID: 37803040
- DOI: 10.1038/s41598-023-43040-x
The outbreak of Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, forced us to face a pandemic with unprecedented social, economic, and public health consequences. Several nations have launched campaigns to immunize millions of people using various vaccines to prevent infections. Meanwhile, therapeutic approaches and discoveries continuously arise; however, identifying infected patients that are going to experience the more severe outcomes of COVID-19 is still a major need, to focus therapeutic efforts, reducing hospitalization and mitigating drug adverse effects. Microbial communities colonizing the respiratory tract exert significant effects on host immune responses, influencing the susceptibility to infectious agents. Through 16S rDNAseq we characterized the upper airways' microbiota of 192 subjects with nasopharyngeal swab positive for SARS-CoV-2. Patients were divided into groups based on the presence of symptoms, pneumonia severity, and need for oxygen therapy or intubation. Indeed, unlike most of the literature, our study focuses on identifying microbial signatures predictive of disease progression rather than on the probability of infection itself, for which a consensus is lacking. Diversity, differential abundance, and network analysis at different taxonomic levels were synergistically adopted, in a robust bioinformatic pipeline, highlighting novel possible taxa correlated with patients' disease progression to intubation.